Radiofrequency treatment to reduce blood transfusions in GAVE
Part of Digestive system, Heart & circulation clinical trials.
This trial tests a procedure called endoscopic radiofrequency treatment to see if it can reduce the need for blood transfusions in people with GAVE, a condition that causes bleeding in the stomach. If you have ongoing bleeding or anemia despite iron therapy, this treatment might help stop the bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have been diagnosed with GAVE (a condition that causes bleeding spots in the stomach lining).
- You have had black or bloody stools, vomited blood, or anemia that hasn't improved with iron therapy for at least 6 months.
- You had a colonoscopy in the last year that showed no other cause of bleeding.
- You are not pregnant, do not have active cancer, and do not have a bleeding disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a freezing spray (Tru-Freeze) to treat GAVE, a condition that causes stomach bleeding. It may help people who need blood transfusions because of GAVE and have had few or no prior endoscopic treatments.
This trial tests whether giving iron after a non–life-threatening stomach or bowel bleed can help rebuild blood levels and prevent problems related to iron deficiency. You would need to be stable after the bleeding is treated and meet specific blood and health criteria.
This trial compares two treatments for anemia caused by abnormal blood vessels in the stomach (GAVE) in people with cirrhosis. It tests whether a medicine called thalidomide is better than a procedure that uses a tiny argon plasma beam to stop bleeding, to see which helps treat anemia more effectively.
This study looks at people with a stomach condition called gastric antral vascular ectasia (GAVE) to understand how it affects digestion and causes symptoms. Researchers want to learn if stomach muscle function problems are common in this condition.
This study looks at whether radiofrequency ablation can help people with moderate to severe damage and cell changes in their stomach lining. It aims to see if this treatment can improve the condition and possibly prevent it from getting worse.
This trial tests whether a medicine called tranexamic acid can help reduce the need for blood transfusions during major abdominal surgeries. It's for people having surgery to remove part of the esophagus, stomach, colon, rectum, pancreas, or liver.
Hear when a new GAVE - Gastric Antral Vascular Ectasia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.